Few research have assessed traits in gross sales or use of tobacco products across the EVALI (Vape E Juice-cigarette, Vape Shop or vaping, product use-associated lung harm) outbreak, Vape Shop and Discount Vape none have assessed the changes in sales of nicotine replacement therapy (NRT) merchandise around the outbreak. We used Nielsen retail sales data to evaluate tendencies in sales of e-cigarettes, cigarettes, and nicotine replacement therapy (NRT) merchandise earlier than, Vape Shop during, and after the EVALI outbreak.
Sales tendencies by aggregated state-level EVALI case prevalence (low, medium, and Cheapest Vape high) were assessed to analyze interstate variations in adjustments of gross sales coinciding with the EVALI outbreak. Monthly unit gross sales of e-cigarettes, Vape Shop cigarettes, and NRT products overall and by product sort were assessed throughout January 2019 through June 2020 through the use of an interrupted time collection mannequin.
